IL2 and breast cancer: In MCF breast cancer cells the expression of a cell cycle regulator p53 was significantly elevated after combined treatment with IFN-γ/TNF-α, but not significantly up-regulated by co-culture with IL-2/IL-12/IL-18-stimulated γδ T cells.